Omaxe Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 4,838.6 million compared to INR 4,497 million a year ago. Revenue was INR 4,998.4 million compared to INR 4,650.8 million a year ago. Net loss was INR 2,424.4 million compared to INR 1,202.5 million a year ago. Basic loss per share from continuing operations was INR 13.25 compared to INR 6.57 a year ago. Diluted loss per share from continuing operations was INR 13.25 compared to INR 6.57 a year ago.